{
  "id": 2103976,
  "title": "Opinion: Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a study",
  "url": "https://urgent.news/2026/08/20/opinion-capricors-duchenne-muscular-dystrophy-drug-and-the-countless",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-20T08:30:00.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/2026/08/20/capricor-deramiocel-duchenne-muscular-dystrophy-rare-disease-studies-decisions/"
  },
  "original_language": "en",
  "account": null,
  "summary": "“Regulatory flexibility can be exercised in rare disease without sacrificing rigor,” writes Mindy Leffler, whose son has Duchenne muscular dystrophy.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "STAT News",
        "title": "STAT+: Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection",
        "url": "https://urgent.news/2026/08/20/stat-capricor-therapeutics-duchenne-treatment-is-heading-for-an-fda",
        "published": "2026-08-20T10:30:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}